Technology Solutions

BioClinica Increases Offer to Buy etrials Worldwide

Thursday, May 21, 2009 08:30 AM

BioClinica, formerly Bio-Imaging Technologies, increased the value of its offer to acquire troubled eClinical vendor etrials Worldwide in response to an unsolicited offer received by etrials from an unrelated third party.

More... »

BioClinica Profits Down, Revenues Up Due to Acquisition

Wednesday, May 6, 2009 10:07 AM

BioClinica, the recently renamed and rebranded Bio-Imaging Technologies, reported a 31% drop in profit for the first quarter 2009 compared with the same period last year. Net income decreased from $1.14 million, or $0.09 per diluted share, in 2008, to $786,000, or $0.05 per diluted share, for Q1 2009.

More... »

Bio-Imaging to Acquire etrials

Tuesday, May 5, 2009 08:40 AM

Only a week after Bio-Imaging Technologies announced a name change to BioClinica and alluded to future acquisitions, the contract research organization (CRO) announced this morning its intent to acquire troubled eClinical vendor etrials Worldwide.

More... »

Phase Forward Beats Sales, Profit Guidance and Stock Soars 30%

Wednesday, April 29, 2009 09:40 AM

Waltham, Mass.-based eClinical company Phase Forward reported first quarter revenues jumped 28% to $48.8 million, compared with the first quarter of 2008.

More... »

Bio-Imaging Technologies Changes Name to BioClinica, Expects to Acquire More Companies

Tuesday, April 28, 2009 09:05 AM

Now that Newtown, Pa.-based contract research organization Bio-Imaging Technologies has completed its integration of Phoenix Data Systems, which it acquired in March 2008, the company has changed its name to BioClinica. The new name also marks the start of an active acquisition phase for the 450-employee company, which plans to acquire more companies in the clinical research services space.

More... »

Global Acquisitions Heat Up

Monday, April 27, 2009 08:00 AM

Three companies—Phase Forward, Chiltern International and ChemDiv—are the latest clinical trial companies to complete global acquisitions.

More... »

Phase Forward Acquires Waban Software

Thursday, April 23, 2009 07:12 AM

Phase Forward, an eClinical company, acquired Waban Software, a Cambridge, Mass.-based clinical data analysis and reporting company with operations in Mumbai, India, for $14 million in cash.

More... »

CenterWatch Announces May Release of “State of the Clinical Trials Industry”

Friday, April 17, 2009 08:00 AM

CenterWatch, a global source for clinical trials information, announced today the planned release of its fifth edition of the annual sourcebook, State of the Clinical Trials Industry, due out in late May.

More... »

CenterWatch Monthly April 2009

Friday, April 10, 2009 08:00 AM

Pfizer’s Enhanced Clinical Trial Design Saves $100 Million Annually

More... »

Oracle to Acquire Relsys

Wednesday, March 25, 2009 08:00 AM

Business software company Oracle has agreed to acquire Relsys, a provider of drug safety and risk management applications, for an undisclosed amount. The deal is expected to close by summer.

More... »